Pharmaceutical Engineering Advances: Improving Drug Development and Production
Keywords:
Pharmaceutical Engineering, Drug Formulation, Process Optimization, Quality Control, Emerging TrendsAbstract
Pharmaceutical engineering is essential to the creation, manufacturing, improvement of pharmaceutical products. Due to technological advancements and a better understanding of the workings of the pharmaceutical industry, this sector has achieved great progress over the past few decades. This review article emphasizes significant developments in pharmaceutical engineering with an emphasis on new trends, process optimization, quality control, drug formulation.
Pharmaceutical engineering is essential to the creation, manufacturing, improvement of pharmaceutical products. Due to technological advancements and a better understanding of the workings of the pharmaceutical industry, this sector has achieved great progress over the past few decades. This review article emphasizes significant developments in pharmaceutical engineering with an emphasis on new trends, process optimization, quality control, drug formulation.
The advent of continuous manufacturing and process analytical technology has increased the prominence of process optimization
and automation. These innovations not only increase production effectiveness but also guarantee consistent product quality in line with legal requirements.
Innovations in quality assurance and control have been made possible by sophisticated analytical methods and digitization. These techniques support the safety and effectiveness of pharmaceutical products by enabling real-time monitoring, data integrity, accurate characterisation of complicated compounds.
Pharmaceutical engineering is expected to change as a result of new trends like customized medicine, sustainable production,
biopharmaceutical advances. This dynamic environment highlights the critical contribution of pharmaceutical engineering to the advancement of drug development, production, patient-centric treatment paradigms, which will shape the future of healthcare.
References
Adams, M. L., & Lavasanifar, A. (2003). Kinetically controlled drug delivery systems for oral administration. Journal of Controlled Release, 86(1), 15-28.
Choonara, Y. E., Pillay, V., Danckwerts, M. P., & Carmichael, T. (2014). 3D-printing and the effect on medical costs: A new era? Expert Review of Pharmacoeconomics & Outcomes Research, 14(5), 697-703.
De Geyter, N., Morent, R., & Leys, C. (2012). Surface modification of polymers by plasmas and photons. Surface and Coatings Technology, 206(23), 5246-5257.
Himmelstein, D. S., Baranzini, S. E., & Carrera, P. (2017). Big data in medicine—A future of personalized medicine? BMC Medicine, 15(1), 1-4.
ICH Harmonised Guideline (2005). Pharmaceutical Development Q8(R2). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
Jain, K., & Awasthi, A. M. (2013). Nanoparticulate drug delivery systems: An overview. Tropical Journal of Pharmaceutical Research, 12(4), 553-562.
Kauffman, J. F., Kiser, P. F., & Alarie, J. P. (2008). State of the art in the design of solid oral dosage forms. In Pharmaceutical dosage forms: Tablets (Vol. 2, pp. 49- 76). Informa Health Care.
Lee, Y. H., Kim, K. H., & Kim, K. (2019). Emerging trends in biopharmaceutical manufacturing and outsourcing. Industrial & Engineering Chemistry Research, 58(1), 197-209.
Löbmann, K., Grohganz, H., & Laitinen, R. (2013). Quality by design in the development of pharmaceuticals: A mechanistic perspective. European Journal of Pharmaceutics and Biopharmaceutics, 85(3), 873-888.
Marrache, S., & Dhar, S. (2012). Engineering of blended nanoparticle platform for delivery of mitochondriaacting therapeutics. Proceedings of the National Academy of Sciences, 109(40), 16288-16293.
Nannan, L., Feng, Z., Shuai, H., & Dianwen, J. (2018). The application of continuous manufacturing technology in pharmaceutical industry. Chinese Chemical Letters, 29(11), 1605-1610
Nichols, J. E., & Niles, J. A. (2020). Application of process analytical technology (PAT) in the biopharmaceutical industry. Biotechnology Advances, 39, 107440.
Praphakar, R. A., & Ganguly, S. (2014). An overview on the continuous manufacturing of solid dosage forms using hot melt extrusion. Pharmaceutical Manufacturing, 16(3), 42-48.
Rathore, A. S., & Winkle, H. (2009). Quality by design for biopharmaceuticals. Nature Biotechnology, 27(1), 26-34.
Roach, L. S., Song, Y., & Isquith, A. J. (2015). Continuous manufacturing of pharmaceuticals. Chemical Engineering Science, 125, 73-84.
Sharma, V., Patel, H. M., & Dodiya, S. S. (2016). Personalized medicine: The road ahead. International Journal of Drug Development & Research, 8(1), 52-63.
Siegel, R. A., & Rathore, A. S. (2017). Lifecycle approach to pharmaceutical process validation: Opportunities for continuous processing. Journal of Pharmaceutical Sciences, 106(10), 2738-2745.
Timmins, P., & Sewell, G. (2000). Pharmaceutical manufacturing in the 21st century: The need for change. Journal of Pharmaceutical Sciences, 89(6), 697-700
